**Core Concept**
Nitric oxide (NO) plays a crucial role in the regulation of vascular tone by inducing relaxation of vascular smooth muscle cells and vasodilation of arterioles. This process is mediated through the activation of guanylate cyclase, leading to an increase in cyclic guanosine monophosphate (cGMP) levels.

**Why the Correct Answer is Right**
At the site of myocardial infarction, the endothelial dysfunction triggers the release of endothelium-derived relaxing factor (EDRF), which is primarily composed of nitric oxide (NO). NO then diffuses into the vascular smooth muscle cells, activating guanylate cyclase and increasing cGMP levels, resulting in vasodilation and increased blood flow to the affected area. This compensatory response is an attempt to counteract the ischemic damage caused by the myocardial infarction.

**Why Each Wrong Option is Incorrect**
**Option A:** Prostaglandin I2 (PGI2) is a potent vasodilator, but it is not the primary mediator of inflammation causing vasodilation in the context of myocardial infarction.
**Option B:** Vasoconstrictors like endothelin-1 (ET-1) are often released in response to inflammation, leading to vasoconstriction rather than vasodilation.
**Option C:** Interleukin-1 beta (IL-1β) is a pro-inflammatory cytokine that promotes inflammation, but it does not directly cause vasodilation.

**Clinical Pearl / High-Yield Fact**
In the setting of myocardial infarction, the release of nitric oxide (NO) can lead to vasodilation and increased blood flow to the affected area, which may paradoxically worsen ischemia in the early stages due to increased myocardial oxygen demand.

**Correct Answer:** C. Nitric oxide (NO)